1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Induced Pluripotent Stem Cells Revenue 1.4 Market by Type 1.4.1 Global Induced Pluripotent Stem Cells Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Hepatocytes 1.4.3 Fibroblasts 1.4.4 Keratinocytes 1.4.5 Amniotic Cells 1.4.6 Others 1.5 Market by Application 1.5.1 Global Induced Pluripotent Stem Cells Market Share by Application: 2020 VS 2026 1.5.2 Academic Research 1.5.3 Drug Development And Discovery 1.5.4 Toxicity Screening 1.5.5 Regenerative Medicine 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Global Induced Pluripotent Stem Cells Market Perspective (2015-2026) 2.2 Global Induced Pluripotent Stem Cells Growth Trends by Regions 2.2.1 Induced Pluripotent Stem Cells Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Induced Pluripotent Stem Cells Historic Market Share by Regions (2015-2020) 2.2.3 Induced Pluripotent Stem Cells Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Induced Pluripotent Stem Cells Market Growth Strategy 2.3.6 Primary Interviews with Key Induced Pluripotent Stem Cells Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Induced Pluripotent Stem Cells Players by Market Size 3.1.1 Global Top Induced Pluripotent Stem Cells Players by Revenue (2015-2020) 3.1.2 Global Induced Pluripotent Stem Cells Revenue Market Share by Players (2015-2020) 3.1.3 Global Induced Pluripotent Stem Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Induced Pluripotent Stem Cells Market Concentration Ratio 3.2.1 Global Induced Pluripotent Stem Cells Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Induced Pluripotent Stem Cells Revenue in 2019 3.3 Induced Pluripotent Stem Cells Key Players Head office and Area Served 3.4 Key Players Induced Pluripotent Stem Cells Product Solution and Service 3.5 Date of Enter into Induced Pluripotent Stem Cells Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Induced Pluripotent Stem Cells Historic Market Size by Type (2015-2020) 4.2 Global Induced Pluripotent Stem Cells Forecasted Market Size by Type (2021-2026) 5 Market Size by Application (2015-2026) 5.1 Global Induced Pluripotent Stem Cells Market Size by Application (2015-2020) 5.2 Global Induced Pluripotent Stem Cells Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Induced Pluripotent Stem Cells Market Size (2015-2020) 6.2 Induced Pluripotent Stem Cells Key Players in North America (2019-2020) 6.3 North America Induced Pluripotent Stem Cells Market Size by Type (2015-2020) 6.4 North America Induced Pluripotent Stem Cells Market Size by Application (2015-2020) 7 Europe 7.1 Europe Induced Pluripotent Stem Cells Market Size (2015-2020) 7.2 Induced Pluripotent Stem Cells Key Players in Europe (2019-2020) 7.3 Europe Induced Pluripotent Stem Cells Market Size by Type (2015-2020) 7.4 Europe Induced Pluripotent Stem Cells Market Size by Application (2015-2020) 8 China 8.1 China Induced Pluripotent Stem Cells Market Size (2015-2020) 8.2 Induced Pluripotent Stem Cells Key Players in China (2019-2020) 8.3 China Induced Pluripotent Stem Cells Market Size by Type (2015-2020) 8.4 China Induced Pluripotent Stem Cells Market Size by Application (2015-2020) 9 Japan 9.1 Japan Induced Pluripotent Stem Cells Market Size (2015-2020) 9.2 Induced Pluripotent Stem Cells Key Players in Japan (2019-2020) 9.3 Japan Induced Pluripotent Stem Cells Market Size by Type (2015-2020) 9.4 Japan Induced Pluripotent Stem Cells Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Induced Pluripotent Stem Cells Market Size (2015-2020) 10.2 Induced Pluripotent Stem Cells Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Induced Pluripotent Stem Cells Market Size by Type (2015-2020) 10.4 Southeast Asia Induced Pluripotent Stem Cells Market Size by Application (2015-2020) 11 India 11.1 India Induced Pluripotent Stem Cells Market Size (2015-2020) 11.2 Induced Pluripotent Stem Cells Key Players in India (2019-2020) 11.3 India Induced Pluripotent Stem Cells Market Size by Type (2015-2020) 11.4 India Induced Pluripotent Stem Cells Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Induced Pluripotent Stem Cells Market Size (2015-2020) 12.2 Induced Pluripotent Stem Cells Key Players in Central & South America (2019-2020) 12.3 Central & South America Induced Pluripotent Stem Cells Market Size by Type (2015-2020) 12.4 Central & South America Induced Pluripotent Stem Cells Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Fujifilm Holding Corporation 13.1.1 Fujifilm Holding Corporation Company Details 13.1.2 Fujifilm Holding Corporation Business Overview 13.1.3 Fujifilm Holding Corporation Induced Pluripotent Stem Cells Introduction 13.1.4 Fujifilm Holding Corporation Revenue in Induced Pluripotent Stem Cells Business (2015-2020)) 13.1.5 Fujifilm Holding Corporation Recent Development 13.2 Astellas Pharma 13.2.1 Astellas Pharma Company Details 13.2.2 Astellas Pharma Business Overview 13.2.3 Astellas Pharma Induced Pluripotent Stem Cells Introduction 13.2.4 Astellas Pharma Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.2.5 Astellas Pharma Recent Development 13.3 Fate Therapeutics 13.3.1 Fate Therapeutics Company Details 13.3.2 Fate Therapeutics Business Overview 13.3.3 Fate Therapeutics Induced Pluripotent Stem Cells Introduction 13.3.4 Fate Therapeutics Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.3.5 Fate Therapeutics Recent Development 13.4 Bristol-Myers Squibb Company 13.4.1 Bristol-Myers Squibb Company Company Details 13.4.2 Bristol-Myers Squibb Company Business Overview 13.4.3 Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Introduction 13.4.4 Bristol-Myers Squibb Company Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.4.5 Bristol-Myers Squibb Company Recent Development 13.5 ViaCyte 13.5.1 ViaCyte Company Details 13.5.2 ViaCyte Business Overview 13.5.3 ViaCyte Induced Pluripotent Stem Cells Introduction 13.5.4 ViaCyte Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.5.5 ViaCyte Recent Development 13.6 Celgene Corporation 13.6.1 Celgene Corporation Company Details 13.6.2 Celgene Corporation Business Overview 13.6.3 Celgene Corporation Induced Pluripotent Stem Cells Introduction 13.6.4 Celgene Corporation Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.6.5 Celgene Corporation Recent Development 13.7 Aastrom Biosciences 13.7.1 Aastrom Biosciences Company Details 13.7.2 Aastrom Biosciences Business Overview 13.7.3 Aastrom Biosciences Induced Pluripotent Stem Cells Introduction 13.7.4 Aastrom Biosciences Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.7.5 Aastrom Biosciences Recent Development 13.8 Acelity Holdings 13.8.1 Acelity Holdings Company Details 13.8.2 Acelity Holdings Business Overview 13.8.3 Acelity Holdings Induced Pluripotent Stem Cells Introduction 13.8.4 Acelity Holdings Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.8.5 Acelity Holdings Recent Development 13.9 StemCells 13.9.1 StemCells Company Details 13.9.2 StemCells Business Overview 13.9.3 StemCells Induced Pluripotent Stem Cells Introduction 13.9.4 StemCells Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.9.5 StemCells Recent Development 13.10 Japan Tissue Engineering 13.10.1 Japan Tissue Engineering Company Details 13.10.2 Japan Tissue Engineering Business Overview 13.10.3 Japan Tissue Engineering Induced Pluripotent Stem Cells Introduction 13.10.4 Japan Tissue Engineering Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 13.10.5 Japan Tissue Engineering Recent Development 13.11 Organogenesis 10.11.1 Organogenesis Company Details 10.11.2 Organogenesis Business Overview 10.11.3 Organogenesis Induced Pluripotent Stem Cells Introduction 10.11.4 Organogenesis Revenue in Induced Pluripotent Stem Cells Business (2015-2020) 10.11.5 Organogenesis Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Induced Pluripotent Stem Cells Key Market Segments Table 2. Key Players Covered: Ranking by Induced Pluripotent Stem Cells Revenue Table 3. Ranking of Global Top Induced Pluripotent Stem Cells Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Induced Pluripotent Stem Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Hepatocytes Table 6. Key Players of Fibroblasts Table 7. Key Players of Keratinocytes Table 8. Key Players of Amniotic Cells Table 9. Key Players of Others Table 10. Global Induced Pluripotent Stem Cells Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 11. Global Induced Pluripotent Stem Cells Market Size by Regions (US$ Million): 2020 VS 2026 Table 12. Global Induced Pluripotent Stem Cells Market Size by Regions (2015-2020) (US$ Million) Table 13. Global Induced Pluripotent Stem Cells Market Share by Regions (2015-2020) Table 14. Global Induced Pluripotent Stem Cells Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 15. Global Induced Pluripotent Stem Cells Market Share by Regions (2021-2026) Table 16. Market Top Trends Table 17. Key Drivers: Impact Analysis Table 18. Key Challenges Table 19. Induced Pluripotent Stem Cells Market Growth Strategy Table 20. Main Points Interviewed from Key Induced Pluripotent Stem Cells Players Table 21. Global Induced Pluripotent Stem Cells Revenue by Players (2015-2020) (Million US$) Table 22. Global Induced Pluripotent Stem Cells Market Share by Players (2015-2020) Table 23. Global Top Induced Pluripotent Stem Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Induced Pluripotent Stem Cells as of 2019) Table 24. Global Induced Pluripotent Stem Cells by Players Market Concentration Ratio (CR5 and HHI) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Induced Pluripotent Stem Cells Product Solution and Service Table 27. Date of Enter into Induced Pluripotent Stem Cells Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Induced Pluripotent Stem Cells Market Size by Type (2015-2020) (Million US$) Table 30. Global Induced Pluripotent Stem Cells Market Size Share by Type (2015-2020) Table 31. Global Induced Pluripotent Stem Cells Revenue Market Share by Type (2021-2026) Table 32. Global Induced Pluripotent Stem Cells Market Size Share by Application (2015-2020) Table 33. Global Induced Pluripotent Stem Cells Market Size by Application (2015-2020) (Million US$) Table 34. Global Induced Pluripotent Stem Cells Market Size Share by Application (2021-2026) Table 35. North America Key Players Induced Pluripotent Stem Cells Revenue (2019-2020) (Million US$) Table 36. North America Key Players Induced Pluripotent Stem Cells Market Share (2019-2020) Table 37. North America Induced Pluripotent Stem Cells Market Size by Type (2015-2020) (Million US$) Table 38. North America Induced Pluripotent Stem Cells Market Share by Type (2015-2020) Table 39. North America Induced Pluripotent Stem Cells Market Size by Application (2015-2020) (Million US$) Table 40. North America Induced Pluripotent Stem Cells Market Share by Application (2015-2020) Table 41. Europe Key Players Induced Pluripotent Stem Cells Revenue (2019-2020) (Million US$) Table 42. Europe Key Players Induced Pluripotent Stem Cells Market Share (2019-2020) Table 43. Europe Induced Pluripotent Stem Cells Market Size by Type (2015-2020) (Million US$) Table 44. Europe Induced Pluripotent Stem Cells Market Share by Type (2015-2020) Table 45. Europe Induced Pluripotent Stem Cells Market Size by Application (2015-2020) (Million US$) Table 46. Europe Induced Pluripotent Stem Cells Market Share by Application (2015-2020) Table 47. China Key Players Induced Pluripotent Stem Cells Revenue (2019-2020) (Million US$) Table 48. China Key Players Induced Pluripotent Stem Cells Market Share (2019-2020) Table 49. China Induced Pluripotent Stem Cells Market Size by Type (2015-2020) (Million US$) Table 50. China Induced Pluripotent Stem Cells Market Share by Type (2015-2020) Table 51. China Induced Pluripotent Stem Cells Market Size by Application (2015-2020) (Million US$) Table 52. China Induced Pluripotent Stem Cells Market Share by Application (2015-2020) Table 53. Japan Key Players Induced Pluripotent Stem Cells Revenue (2019-2020) (Million US$) Table 54. Japan Key Players Induced Pluripotent Stem Cells Market Share (2019-2020) Table 55. Japan Induced Pluripotent Stem Cells Market Size by Type (2015-2020) (Million US$) Table 56. Japan Induced Pluripotent Stem Cells Market Share by Type (2015-2020) Table 57. Japan Induced Pluripotent Stem Cells Market Size by Application (2015-2020) (Million US$) Table 58. Japan Induced Pluripotent Stem Cells Market Share by Application (2015-2020) Table 59. Southeast Asia Key Players Induced Pluripotent Stem Cells Revenue (2019-2020) (Million US$) Table 60. Southeast Asia Key Players Induced Pluripotent Stem Cells Market Share (2019-2020) Table 61. Southeast Asia Induced Pluripotent Stem Cells Market Size by Type (2015-2020) (Million US$) Table 62. Southeast Asia Induced Pluripotent Stem Cells Market Share by Type (2015-2020) Table 63. Southeast Asia Induced Pluripotent Stem Cells Market Size by Application (2015-2020) (Million US$) Table 64. Southeast Asia Induced Pluripotent Stem Cells Market Share by Application (2015-2020) Table 65. India Key Players Induced Pluripotent Stem Cells Revenue (2019-2020) (Million US$) Table 66. India Key Players Induced Pluripotent Stem Cells Market Share (2019-2020) Table 67. India Induced Pluripotent Stem Cells Market Size by Type (2015-2020) (Million US$) Table 68. India Induced Pluripotent Stem Cells Market Share by Type (2015-2020) Table 69. India Induced Pluripotent Stem Cells Market Size by Application (2015-2020) (Million US$) Table 70. India Induced Pluripotent Stem Cells Market Share by Application (2015-2020) Table 71. Central & South America Key Players Induced Pluripotent Stem Cells Revenue (2019-2020) (Million US$) Table 72. Central & South America Key Players Induced Pluripotent Stem Cells Market Share (2019-2020) Table 73. Central & South America Induced Pluripotent Stem Cells Market Size by Type (2015-2020) (Million US$) Table 74. Central & South America Induced Pluripotent Stem Cells Market Share by Type (2015-2020) Table 75. Central & South America Induced Pluripotent Stem Cells Market Size by Application (2015-2020) (Million US$) Table 76. Central & South America Induced Pluripotent Stem Cells Market Share by Application (2015-2020) Table 77. Fujifilm Holding Corporation Company Details Table 78. Fujifilm Holding Corporation Business Overview Table 79. Fujifilm Holding Corporation Product Table 80. Fujifilm Holding Corporation Revenue in Induced Pluripotent Stem Cells Business (2015-2020) (Million US$) Table 81. Fujifilm Holding Corporation Recent Development Table 82. Astellas Pharma Company Details Table 83. Astellas Pharma Business Overview Table 84. Astellas Pharma Product Table 85. Astellas Pharma Revenue in Induced Pluripotent Stem Cells Business (2015-2020) (Million US$) Table 86. Astellas Pharma Recent Development Table 87. Fate Therapeutics Company Details Table 88. Fate Therapeutics Business Overview Table 89. Fate Therapeutics Product Table 90. Fate Therapeutics Revenue in Induced Pluripotent Stem Cells Business (2015-2020) (Million US$) Table 91. Fate Therapeutics Recent Development Table 92. Bristol-Myers Squibb Company Company Details Table 93. Bristol-Myers Squibb Company Business Overview Table 94. Bristol-Myers Squibb Company Product Table 95. Bristol-Myers Squibb Company Revenue in Induced Pluripotent Stem Cells Business (2015-2020) (Million US$) Table 96. Bristol-Myers Squibb Company Recent Development Table 97. ViaCyte Company Details Table 98. ViaCyte Business Overview Table 99. ViaCyte Product Table 100. ViaCyte Revenue in Induced Pluripotent Stem Cells Business (2015-2020) (Million US$) Table 101. ViaCyte Recent Development Table 102. Celgene Corporation Company Details Table 103. Celgene Corporation Business Overview Table 104. Celgene Corporation Product Table 105. Celgene Corporation Revenue in Induced Pluripotent Stem Cells Business (2015-2020) (Million US$) Table 106. Celgene Corporation Recent Development Table 107. Aastrom Biosciences Company Details Table 108. Aastrom Biosciences Business Overview Table 109. Aastrom Biosciences Product Table 110. Aastrom Biosciences Revenue in Induced Pluripotent Stem Cells Business (2015-2020) (Million US$) Table 111. Aastrom Biosciences Recent Development Table 112. Acelity Holdings Business Overview Table 113. Acelity Holdings Product Table 114. Acelity Holdings Company Details Table 115. Acelity Holdings Revenue in Induced Pluripotent Stem Cells Business (2015-2020) (Million US$) Table 116. Acelity Holdings Recent Development Table 117. StemCells Company Details Table 118. StemCells Business Overview Table 119. StemCells Product Table 120. StemCells Revenue in Induced Pluripotent Stem Cells Business (2015-2020) (Million US$) Table 121. StemCells Recent Development Table 122. Japan Tissue Engineering Company Details Table 123. Japan Tissue Engineering Business Overview Table 124. Japan Tissue Engineering Product Table 125. Japan Tissue Engineering Revenue in Induced Pluripotent Stem Cells Business (2015-2020) (Million US$) Table 126. Japan Tissue Engineering Recent Development Table 127. Organogenesis Company Details Table 128. Organogenesis Business Overview Table 129. Organogenesis Product Table 130. Organogenesis Revenue in Induced Pluripotent Stem Cells Business (2015-2020) (Million US$) Table 131. Organogenesis Recent Development Table 132. Research Programs/Design for This Report Table 133. Key Data Information from Secondary Sources Table 134. Key Data Information from Primary Sources List of Figures Figure 1. Global Induced Pluripotent Stem Cells Market Share by Type: 2020 VS 2026 Figure 2. Hepatocytes Features Figure 3. Fibroblasts Features Figure 4. Keratinocytes Features Figure 5. Amniotic Cells Features Figure 6. Others Features Figure 7. Global Induced Pluripotent Stem Cells Market Share by Application: 2020 VS 2026 Figure 8. Academic Research Case Studies Figure 9. Drug Development And Discovery Case Studies Figure 10. Toxicity Screening Case Studies Figure 11. Regenerative Medicine Case Studies Figure 12. Induced Pluripotent Stem Cells Report Years Considered Figure 13. Global Induced Pluripotent Stem Cells Market Size YoY Growth 2015-2026 (US$ Million) Figure 14. Global Induced Pluripotent Stem Cells Market Share by Regions: 2020 VS 2026 Figure 15. Global Induced Pluripotent Stem Cells Market Share by Regions (2021-2026) Figure 16. Porter's Five Forces Analysis Figure 17. Global Induced Pluripotent Stem Cells Market Share by Players in 2019 Figure 18. Global Top Induced Pluripotent Stem Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Induced Pluripotent Stem Cells as of 2019 Figure 19. The Top 10 and 5 Players Market Share by Induced Pluripotent Stem Cells Revenue in 2019 Figure 20. North America Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Europe Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2020) (Million US$) Figure 22. China Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Japan Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Southeast Asia Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2020) (Million US$) Figure 25. India Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Central & South America Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2020) (Million US$) Figure 27. Bottom-up and Top-down Approaches for This Report Figure 28. Data Triangulation Figure 29. Key Executives Interviewed

Fujifilm Holding Corporation Astellas Pharma Fate Therapeutics Bristol-Myers Squibb Company ViaCyte Celgene Corporation Aastrom Biosciences Acelity Holdings StemCells Japan Tissue Engineering Organogenesis